These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22665070)

  • 1. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of long-term adverse outcomes in elderly patients over 80 years hospitalized with heart failure. - A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)-.
    Hamaguchi S; Kinugawa S; Goto D; Tsuchihashi-Makaya M; Yokota T; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Circ J; 2011; 75(10):2403-10. PubMed ID: 21778592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atrial fibrillation on long-term outcomes in patients hospitalized for heart failure in Japan: a report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
    Hamaguchi S; Yokoshiki H; Kinugawa S; Tsuchihashi-Makaya M; Yokota T; Takeshita A; Tsutsui H;
    Circ J; 2009 Nov; 73(11):2084-90. PubMed ID: 19755750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia is an independent predictor of adverse clinical outcomes in hospitalized patients due to worsening heart failure.
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Matsushima S; Sakakibara M; Ishimori N; Goto D; Tsutsui H
    J Cardiol; 2014 Mar; 63(3):182-8. PubMed ID: 24021776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
    Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
    JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
    Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH;
    Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan. A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
    Hamaguchi S; Tsuchihashi-Makaya M; Kinugawa S; Yokota T; Takeshita A; Yokoshiki H; Tsutsui H;
    Circ J; 2009 Oct; 73(10):1901-8. PubMed ID: 19652398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
    Hamaguchi S; Tsuchihashi-Makaya M; Kinugawa S; Yokota T; Ide T; Takeshita A; Tsutsui H;
    Circ J; 2009 Aug; 73(8):1442-7. PubMed ID: 19521016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekend versus weekday hospital admission and outcomes during hospitalization for patients due to worsening heart failure: a report from Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Tsutsui H
    Heart Vessels; 2014 May; 29(3):328-35. PubMed ID: 23653107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
    Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
    Tsuchihashi-Makaya M; Hamaguchi S; Kinugawa S; Yokota T; Goto D; Yokoshiki H; Kato N; Takeshita A; Tsutsui H;
    Circ J; 2009 Oct; 73(10):1893-900. PubMed ID: 19644216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
    Faselis C; Arundel C; Patel S; Lam PH; Gottlieb SS; Zile MR; Deedwania P; Filippatos G; Sheriff HM; Zeng Q; Morgan CJ; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2020 Aug; 76(6):669-679. PubMed ID: 32762901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
    J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics, management, and outcomes for patients during hospitalization due to worsening heart failure-A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Tsutsui H
    J Cardiol; 2013 Aug; 62(2):95-101. PubMed ID: 23672787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.
    Fudim M; O'Connor CM; Mulder H; Coles A; Bhatt AS; Ambrosy AP; Kraus WE; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 Nov; 205():133-141. PubMed ID: 30158057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia predicts adverse outcomes in patients with heart failure.
    Hamaguchi S; Furumoto T; Tsuchihashi-Makaya M; Goto K; Goto D; Yokota T; Kinugawa S; Yokoshiki H; Takeshita A; Tsutsui H;
    Int J Cardiol; 2011 Sep; 151(2):143-7. PubMed ID: 20542341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker use at discharge in patients hospitalized for heart failure is associated with improved survival.
    Tsuchihashi-Makaya M; Kinugawa S; Yokoshiki H; Hamaguchi S; Yokota T; Goto D; Goto K; Takeshita A; Tsutsui H;
    Circ J; 2010 Jul; 74(7):1364-71. PubMed ID: 20501958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.